| Literature DB >> 31024886 |
Jhonys Machado Freitas1, Thiago da Costa Oliveira1, Rodrigo Alejandro Abarza Munoz1, Eduardo Mathias Richter1.
Abstract
Boron-doped diamond (BDD) electrodes present several notable properties, such as the largest potential window of all electrode materials (especially in anodic potentials), low background and capacitive currents, reduced fouling compared to other electrodes, mechanical robustness, and good stability over time. On the other hand, flow-based systems are known as well-established approaches to minimize reagent consumption and waste generation and with good compromise between sample throughput and analytical performance (mechanization of chemical assays). This review focuses on the use of BDD electrodes for electrochemical detection in flow systems, such as flow injection analysis (FIA), batch injection analysis (BIA), high performance liquid chromatography (HPLC), and capillary electrophoresis (CE). The discussion deals with the historical evolution of BDD, types of electrochemical pre-treatments (cathodically/H-terminated or anodically/O-terminated), cell configurations, and analytical performance. Articles are discussed in chronological order and subdivided according to the type of flow system: FIA, BIA, HPLC, and CE.Entities:
Keywords: batch injection analysis; capillary electrophoresis; flow injection analysis; liquid chromatography; review
Year: 2019 PMID: 31024886 PMCID: PMC6463006 DOI: 10.3389/fchem.2019.00190
Source DB: PubMed Journal: Front Chem ISSN: 2296-2646 Impact factor: 5.221
Figure 1(A) Schematic diagram of batch injection analysis (BIA) and (B) flow injection analysis (FIA) cells for BDD electrodes.
FIA systems with electrochemical detection using BDD as the working electrode.
| AMP | As received | Ethylamine (EA) | SS | 5 (EA and EDA) | 10–1,000 (EA) | 40 | Jolley et al., |
| AMP | Hydrogen plasma (800°C/30 min) | Chlorpromazine (CPM) | SS | 0.004 (CPM) | 0.3–3,000 (CPM) 0.1–3,000 (AA, DP and 4-MC) | NR | Granger et al., |
| AMP | NR | Histamine (HIS) | SS | 0.5 (HIS) | 0.5–100 (HIS) | 40 | Sarada et al., |
| AMP | As received | Cadaverine (CAD) | SS | 1.0(CAD/PUT/SPD) | 1.0–1,000 (CAD, PUT and SPD) | NR | Witek and Swain, |
| AMP | As received | Glutathione (GLU) | NR | 0.5 (GLU) | 0.5–100 (GLU) | NR | Hailapakul et al., |
| AMP | As received | Acetaminophen | PF | 0.01 | 0.5–50 | 76 | Wangfuengkanagul and Chailapakul, |
| AMP | +3.0 V/30 min 0.1 M H2SO4 | Bisphenol-A | NR | 1 | 1–100 | 30 | Notsu et al., |
| AMP | As received | D-penicillamine | PF | 0.01 | 0.5–50 | 54 | Wangfuengkanagul and Chailapakul, |
| AMP | As received | Captopril | PF | 0.01 | 0.5–100 | 35 | Siangproh et al., |
| AMP | As received | Tiopronin | SS and PF | 0.01 | 0.5–50 | NR | Siangproh et al., |
| AMP | Cyclic voltammetry (0–2.2 V)/30 min/0.1 M KOH | Tetracycline | PF | 0.01 | 0.5–50 | NR | Wangfuengkanagul et al., |
| AMP | As received | Iodide ion | PF | 0.01 | 0.8–200 | 85 | Chailapakul et al., |
| AMP | As received | Sodium thiosulphate | SS | 0.2 | 0.5–100 | 180 | Suryanarayanan et al., |
| AMP | NR | Glucose | SS | 0.67 (Ni-BDD) | 1–50 | NR | Ivandini et al., |
| AMP | As received | Lincomycin | PF | 0.02 | 0.5–125 | 90 | Boonsong et al., |
| AMP | NR | Hydrogen peroxide | SS | 0.05 | 0.1–10 | NR | Ivandini et al., |
| AMP | As received | Tetracycline | PF | 0.01 | 1–100 | NR | Treetepvijit et al., |
| AMP | −3.0 V/30 min/0.1 M BR buffer, pH = 5.0 | Rutin | Tea samples | 7.7 | 10–250 | 100 | Pedrosa et al., |
| PAD | As received | Salbutamol (SBM) | PF | 0.1 (SMB) | 0.5–100 (SBM) | NR | Karuwan et al., |
| AMP | As received | Malachite green (MG) Leucomalachite green (LMG) | SS | 0.05 for both | 1–100 (MC) | 144 | Ngamukot et al., |
| AMP | As received | Sulfonamides | Eggs | 0.04 (SDZ) | 0.2–400 (SDZ) | NR | Preechaworapun et al., |
| AMP | As received | Arsenite (As(III)) | Tap water | 0.02 | 0.1–100 | 30 | Ivandini et al., |
| AMP | As received | Chloramphenicol | PF/Milk samples | 0.03 | 0.1–50 | 60 | Chuanuwatanakul et al., |
| AMP | −3 V/10/0.1 M PBS pH 7.4. | Bovine serum albumin (BSA) | SS | 0.76 for BSA2.0 for IAP | 0.76–455 BSA | 48 | Chiku et al., |
| AMP | As received | Oxalate | SS | 0.03 | 0.8–100.0 | 23 | Kondo et al., |
| MPA | −1.0 A cm−2/120 s/0.5 M H2SO4 | BHA | Food samples | 0.03 (BHA) | 0.05–3.0 (BHA) | 63 | Medeiros et al., |
| MPA | −3.0 V/900 s/0.5 M H2SO4 | Paracetamol (PAR) | PF | 0.7 (PAR) | 53–1,300 for PAR | 140 | Silva et al., |
| MPA | 3.0 V/900 s/0.5 M H2SO4 | Diclofenac (DCF) | PF | 0.1 | 5–50.0 | 135 | Gimenes et al., |
| MPA | −9 C cm−2 0.5 M H2SO4 | Sildenafil citrate | PF | 0.4 | 2–100 | 86 | Lopes Júnior et al., |
| MPA | 0.5 A cm−2/60 s and −0.5 A cm−2 for 180 s/0.5 M H2SO4 | Tartrazine and sunset yellow (TT–SY) | Food samples | 2.5 (TT) | 5–60 (TT) | 80 | Medeiros et al., |
| Brilliant blue and SY (BB–SY) | 3.5 (BB) | 5–60 (BB) | |||||
| AMP | +11.7 mA/30 s/0.5 M H2SO4 | Nimesulide | PF | 0.08 | 4–80 | 90 | Pereira et al., |
| AMP | −2.0 V/60 s/0.5 M H2SO4 | Yohimbine | Dietary supplements | 0.2 | 0.3–10 | 70 | Švorc and Kalcher, |
| FBA-DPASV | −50 mA cm−2/120 s/0.1 M H2SO4. | Zn2+ | Water samples | 9.2 × 10−3 (Zn2+) | 0.18–1.23 (Zn2+) | 12 | Bezerra dos Santos et al., |
| MCFA–MPA | 3.4 (Zn2+) | 12.7–76.2 (Zn2+) | 67 | ||||
| AMP | As received | Hydrogen Sulfide | Aqueous solutions | 0.4 | 1–51 | 24 | Bitziou et al., |
| AMP | As received | N-acetyl-l-cysteine (NAC) | PF | 0.01 | 0.5–50 | 64 | Nantaphol et al., |
| AMP | −0.5 A cm−2/360 s/0.50 M H2SO4 | Estrone | Tap and natural waters | 0.01 | 0.1–3.0 | 50 | Brocenschi et al., |
| SWASV | 50 mA cm−2/120 s/0.1 M H2SO4 | Cd2+ | Natural waters | 1.6 × 10−3 (Cd2+) | 0.06–0.45 (Cd2+) | NR | Bezerra dos Santos et al., |
| MPA | −0.01 A/120 s/0.5 M H2SO4 | Caffeine (CAF) | PF | 0.2 (PC) | 14–281 (PC) | 150 | Chaves et al., |
| MPA | 0.5 A cm−2/180 s/0.5 M H2SO4 | Hydrochlorothiazide (HTZ) | PF | 0.2 (HTZ) | 0.4–8.0 (HTZ) | 89 | Lourenção et al., |
| AMP | Polished with alumina slurry (0.05 μm) | Hydrazine (HZ) | PF | 64.5 | 1–100 | NR | Channon et al., |
| MPA | −0.04 A cm−2/180 s/0.5 M H2SO4 | Acetaminophen (ACP) | PF and BF | 0.03 (ACP) | 1–100 (ACP) | 85 | Santos et al., |
| MPA | −0.03 A/360 s/0.5 M H2SO4 | Cotinine (CO) | BF | 0.06 | 0.5–100.0 | 36 | Alecrim et al., |
| AMP | −2.0 V/180 s/1 M H2SO4 | Ziram (pesticide) | Natural water | 0.003 | 0.1–1 | 6 | Stanković and Kalcher, |
| MPA | −0.03 A/360 s/0.5 M H2SO4 | Prazosin | PF | 0.5 | 2–200 | 70 | Guedes et al., |
| AMP | +3.0 V/20 min phosphate buffer (pH 7.4) | Oxytocin and Vasopressin | BF | 0.05 | 0.1–10 | 60 | Asai et al., |
| AMP | As received | Oxalic acid | Natural water | NR | 10–100 | NR | Watanabe et al., |
| AMP | 0.5 A cm−2/60 s and −0.5 A cm−2/180 s/0.5 M H2SO4 | Ivermectin (IVM) and Levamisole (LVM) | 0.03 (IVM) | 0.6–50.0 (IVM) | 48 (IVM) | Lourenção et al., | |
| MPA | −0.04 A cm−2/180 s/0.5 M H2SO4 | Acetaminophen (ACM) | PF and BF | 0.03 (ACM) | 0.08–100 (ACM) | 90 | Santos et al., |
| AMP | As received | Epinephrine (EP) and Acetaminophen (AC) | PF | 0.5 (EP) | 0.6–30.0 (EP) | 45 (EP) | Lourenção et al., |
| MPA | +1 mA/120 s and, −30 mA/360 s/0.5 M H2SO4 | Warfarin | PF | 0.5 | 2–400 | 94 | de Jesus Guedes et al., |
| MPA | −0.10 A cm−2/120 s/0.5 M H2SO4 | Indigo carmine | Candy samples | 0.04 | 0.07–1.0 | 153 | Deroco et al., |
| MPA | −0.03 A/360 s/0.1 M H2SO4 | Colchicine | PF and BF | 0.02 | 0.1–2.0 | 30 | Moreira et al., |
| MPA | 0.03 A/360 s/0.1 M H2SO4 | Verapamil | PF and BF | 0.2 | 0.8–40 | 45 | Barbosa Lima et al., |
| AMP | −2.9 V/340 s/3 M H2SO4 | Hydrogen peroxide | Tooth gel | 1.1 | 9.8–95.9 | 63 | Azevedo et al., |
| MPA | −30 mA/360 s/0.5 M H2SO4; | Oxcarbezepine | PF and BF | 0.4 | 2–80 | 65 | Lima et al., |
DT, detection technique; SS, standard solution; PF, pharmaceutical formulations; BF, biological Fluids; PAD, pulsed amperometric detection; AMP, chronoamperometric detection; MPA, multiple pulse amperometry detection; SWASV, square-wave anodic stripping voltammetry detection; FBA-DPASV, flow-batch analysis with differential pulse anodic stripping voltammetry detection; MCFA–MPA, multicommutation flow analysis with multiple pulse amperometry detection; LOD, limit of detection; AF, analytical frequency; LR, linear range; NR, not reported.
Figure 2Flow manifold developed for FBA-DPASV and MCFA-MPA. The μP1 and μP5 were used to pump 50 μL per pulse of acetic acid/acetate solution at pH 4.0 (1) and 0.1 M H2SO4 (5), respectively. The μP2, μP3, μP4, and μP6 pump 20 μL per pulse of the stock solutions of Zn2+ (2), Pb2+ (3), interferents (4), and samples (6), respectively. SV1 and SV2 are the three-way valves and the waste (7), respectively. Reprinted from Bezerra dos Santos et al. (2014). Reproduced by permission of The Royal Society of Chemistry.
BIA systems with electrochemical detection using BDD as the working electrode.
| DPA or MPA | −3 V/900 s/0.5 M H2SO4 | TBHQ, BHA | Biodiesel and PF | 1.7 (PAR) | NR | 60 | da Silva et al., |
| AMP | −3 V/900 s/0.5 M H2SO4 | BHA | Biodiesel | 0.05 | 10–50 | 120 | Tormin et al., |
| AMP | −3 V/900 s/0.2 M H2SO4 | Hydroquinone | PF | 0.02 | 10–2000 | 70 | Cunha et al., |
| MPA | −0.01 A/1,000 s/0.1 M H2SO4 | Codeine (COD) | PF | 1.0 (COD) | 7–36 (COD) | 300 | Gimenes et al., |
| MPA | −0.01 A/1,000 s/0.1 M H2SO4 | Nimesulide (NIM) | PF | 0.3 (PAR) | 10–50 (NIM) | 46 | Pereira et al., |
| MPA | −0.01 A/1,000 s/0.1 M H2SO4 | Propranolol (PRO) | PF | 0.2 (PRO) | 10–50 (PRO) | 130 | Gimenes et al., |
| MPA | −0.01 A/1,000 s/0.1 M H2SO4 | Diphenhydramine (DIP) | PF | 0.1 (8-CTP) | 10–80 (8-CTP) | 70 | Freitas et al., |
| PAD | −0.01 A/1,000 s/0.1 M H2SO4 | Mancozeb | Insecticide | 0.5 | 40–650 | 90 | Silva et al., |
| MPA | −0.01 A/1,000 s/0.1 M H2SO4 | Picoxystrobin | Natural water | 1.6 | 5–100 | 108 | Dornellas et al., |
| MPA | −0.01 A/1,000 s/0.1 M H2SO4 | Sulfamethoxazole (SMX) and trimethoprim (TMP) | PF | 0.9 (SMX) | 40–198 (SMX) | 75 | Pereira et al., |
| MPA | −0.01 A/1,000 s/0.1 M H2SO4 | Captopril (CAP) | PF | 0.1 (CAP) | 27–81 (CAP) | 100 | Gimenes et al., |
| MPA | −0.01 A/1,000 s/0.1 M H2SO4 | 8-chlorotheophylline (8-CTP) | PF | 0.2 (8-CTP) | 10–100 (8-CTP and DIP) | 60 | Freitas et al., |
| SWV and SWASV | −0.01 A/1,000 s/0.1 M H2SO4 | Zinc | PF | 0.1 (Zn2+) | 3–17 (NAP) | 70 | Oliveira et al., |
| MPA | −0.01 A/1,000 s/0.1 M H2SO4 | Phenazopyridine (PHE) | PF | 0.5 (PHE) | 18–1,500 (STZ) | 70 | Pereira et al., |
| PAD | −0.01 A/1,000 s/0.1 M H2SO4 | Amlodipine (AML) | PF | 0.07 (AML) | 2–100 (AML) | 70 | Silva et al., |
| SWV and MPA | −0.01 A/1,000 s/0.1 M H2SO4 | Cocaine (COC) | Seized cocaine | 0.9 (COC) | 20–100 (COC) | NR | Freitas et al., |
| MPA and SWV/PCA | −0.01 A/1,000 s/0.1 M H2SO4 | Sildenafil | PF | N.R. | 5–150 | 60 | Garcia Cardozo et al., |
| MPA | −0.01 A/1,000 s/0.1 M H2SO4 | Paracetamol (PAR) | PF | 1.3 (PAR) | 7–562 (PAR) | 75 | Silva et al., |
| MPA | −0.01 A/1,000 s/0.1 M H2SO4 | 8-chlorotheophylline (8-CTP) | PF | 0.3 (8-CTP) | 10–100 (8-CTP and DIP) | 120 | Freitas et al., |
| AMP | −0.01 A/1,000 s/0.1 M H2SO4 | Levofloxacin | Tap, aquarium and lake water | 0.1 | 5–100 | 160 | Alencar et al., |
| SWV | −0.01 A/1,000 s/0.1 M H2SO4 | Propyphenazone (PRO) | PF | 0.9 (PRO) | 9–217 (PRO) | 80 | Silva et al., |
| MPA | −0.01 A/1,000 s/0.1 M H2SO4 | Pheniramine (PHE) | PF | 0.6 (PHE) | 16–120 (CHL and PHE) | 80 | Oliveira et al., |
| BIA–SWV | −0.01 A/1,000 s/0.1 M H2SO4 | Sibutramine | Natural products and multivitamins | 0.3 | 18–180 | NR | Freitas et al., |
| BIA–SWV | +0.01 A/1,000 s/0.12 M Britton-Robinson buffer | Scopolamine | Beverage and Urine Samples | 0.2 | 1–20 | NR | Oliveira et al., |
DT, detection technique; DPA, dual pulse amperometry; MPA, multiple pulse amperometry; AMP, amperometry; PAD, pulsed amperometric detection; SWV, square-wave voltammetry; SWASV, square-wave anodic stripping voltammetry; PF, pharmaceutical formulation; LOD, limit of detection; LR, linear range; AF, analytical frequency; NR, not reported.
HPLC systems with electrochemical detection using BDD as the working electrode.
| AMP | As received | Sulfadiazine, sulfamerazine, and sulfamethazine | NR | 0.05 | 0.05–50 for all | 9 | Rao et al., |
| AMP | +2.64 V/4 min/Britton-Robinson Buffer–pH 2 | Chlorophenols | Drainwater | 0.02 | 20–100 for all | 2 | Terashima et al., |
| AMP | As received | Imipramine (IM) | Blood | 0.003 (IM and DE) | 0.05–100 | 3 | Ivandini et al., |
| AMP | +2.4 V/30 min/0.1 M KOH | Homocysteine | – | 0.001 | 0.05–100 | 4 | Chailapakul et al., |
| AMP | As received | Carbofuran (CAN) | Pesticides | 0.06 (CAR) | 0.10–100 | 6 | Rao et al., |
| PAD | Cyclic voltammetry (0–2 V; 10 mV/s)/30 min/0.1 M KOH | Oxytetracyline (OX) | Shrimp | 0.1 (OX) | 0.2–217 (OX) | 2 | Charoenraks et al., |
| AMP | +2.5 V/10 min/mobile phase | 16 polycyclic aromatic hydrocarbons | NR. | 0.01–0.04 | 0.025–50 (depending on each analyte) | 4 | Bouvrette et al., |
| AMP | As received | Oxytetracyline (OX) | Shrimp | 0.02 (OX) | 0.1–217 (OX) | 2 | Treetepvijit et al., |
| AMP | +3.0 V/20 min/Britton Robinson buffer–pH 2.1 | Purine and pyrimidine | DNA | 0.03–0.16 | 0.1–10 for all | 4 | Ivandini et al., |
| AMP | +0.5 A cm−2/60 s/0.5 M H2SO4 | Sulfamethoxazole (SFX) | Bovine milk | 0.1 (SFX) | 0.2–3.2 (SFX) | 2 | Andrade et al., |
| AMP | As received | Amino derivatives of biphenyl | Drinking and river water | 0.1 for all | 0.1–10 for all | 10 | Pecková et al., |
| AMP | −3.0 V/10 min/NR | Nitrazepan (NIT) | Pharmaceutical | 1.8 (NIT) | NR | 3 | Martins et al., |
| AMP | As received | α-lipoic acid | Dietary supplement | 0.01 | 0.05–291 | 10 | Siangproh et al., |
| PAD | −3.0 V/10 min/NR | Methylparaben (MePa) | Shampoo | 2.6 (MePa) | 3.3–131 (MePa) | 7.5 | Martins et al., |
| AMP | NR | Sildenafil (SL), vardenafil (VR), and their main metabolites | Human plasma | 0.006 (SL) | 0.02–0.84 (SL) | 5 | Bartošová et al., |
| AMP | As received | Cholesterol | Meat | 0.008 | 0.02–100 μM | 1 | Kotani et al., |
| AMP | NR | Aminobiphenyls | Synthetic colorant tartrazine | 0.07 (thin-layer) | 0.2–10 (thin-layer) | 10 | Maixnerová et al., |
| AMP | NR | Hydroquinone | – | NR | NR | NR | Mahé et al., |
| AMP | NR | Eleven bioamines | Cortex and hippocampus rats | 0.01–0.44 | 0.05–331 (depending on each analyte) | 2 | Zhang et al., |
| AMP | +0.5 A cm−2/30 s/0.5 M H2SO4 | Estrone (ETE) | Human urine | 0.21 (ETE) | NR | 4 | de Amorim and Andrade, |
| AMP | NR | Cyclovirobuxin D | Tablets and human blood | 0.0005 | 0.0007–4.7 | 2 | Long et al., |
DT, detection technique; LR, linear range; AF, analytical frequency; AMP, amperometry; PAD, pulsed amperometric detection; LOD, limit of detection; NR, not reported.
Conventional and Microchip CE systems with electrochemical detection using BDD as the working electrode.
| AMP | NR | Dopamine (DP) | NR | 0.02 (DP) | 0.1–100 | 3 | Shin et al., |
| AMP | Water rinsed | Catechol (CTC) | Standard solution | 0.1 (CTC) | 0.1–100 (CTC) | 7 | Cvačka et al., |
| AMP | NR | 2-Chlorophenol (2-CP) | Natural water | 1.6 × 10−4 (2-CP) | 1.6 × 10−4 −0.78 (2-CP/3-CP/4-CP) | 4 | Muna et al., |
| AMP | Rinsing/isopropyl alcohol | Dopamine hydrochloride (DA) | Standard solution | 0.04 (DA) | 0.05–100 (DA/NE/NM) | 4 | Park et al., |
| AMP | NR | Norepinephrine (NE) | Biological tissue | 0.05 | 0.08–1.00 | 9 | Quaiserová-Mocko et al., |
| AMP | Sonication/2-propanol/10 min. | 1,3-Dinitrobenzene (1,3-DNB) | NR | 0.42 (1,3 DNB) | 1.2–8.3 (1,3 DNB) | 20 | Wang et al., |
| AMP | Sonication/2-propanol/10 min. | Guanosine (GNS) | NR | 2.2 (GNS) | 50–250 | 18 | Wang et al., |
| AMP | Sonication/2-propanol/10 min. | 4-Aminophenol (4-AP) | NR | 2.0 (4-AP) | 2–50 | 36 | Shin et al., |
DT, detection technique; AF, analytical frequency; LR, linear range; AMP, amperometry; PAD, pulsed amperometric detection; LOD, limit of detection; NR, not reported.